RONALD SHADE
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology ELK GROVE VILLAGE, IL NPI 1720049984
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology IL BeiGene USA, Inc. All categories
General Payments — all program years on this page
$27,364.11
- Category: General Payments
- Program years: PY2018–2024
- Record count: 278
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $4,727.28 across 54 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $3,450.00 | 2 |
| Food and Beverage | $1,277.28 | 52 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| BeiGene USA, Inc. | $1,950.00 | 1 |
| BTG INTERNATIONAL, INC. | $1,500.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $124.20 | 5 |
| Genentech USA, Inc. | $115.40 | 5 |
| E.R. Squibb & Sons, L.L.C. | $104.96 | 4 |
| ABBVIE INC. | $92.94 | 4 |
| Acerta Pharma LLC | $86.45 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $78.31 | 3 |
| PFIZER INC. | $63.25 | 3 |
| Astellas Pharma US Inc | $57.52 | 2 |
| Pharmacosmos Therapeutics Inc. | $49.80 | 2 |
| SERVIER PHARMACEUTICALS LLC | $47.06 | 2 |
| Mirati Therapeutics, Inc. | $39.55 | 1 |
| TerSera Therapeutics LLC | $36.69 | 1 |
| Celgene Corporation | $34.99 | 1 |
| JAZZ PHARMACEUTICALS INC. | $33.92 | 1 |
| GE HEALTHCARE | $32.03 | 1 |
| GlaxoSmithKline, LLC. | $31.85 | 2 |
| Tempus AI, Inc | $29.57 | 1 |
| Regeneron Healthcare Solutions, Inc. | $28.72 | 1 |
| Stemline Therapeutics Inc. | $28.47 | 1 |
| Blueprint Medicines Corporation | $25.43 | 1 |
| Merck Sharp & Dohme Corporation | $24.30 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $21.75 | 1 |
| Janssen Biotech, Inc. | $21.12 | 1 |
| Gilead Sciences, Inc. | $20.89 | 1 |
| GENZYME CORPORATION | $17.61 | 1 |
| Lilly USA, LLC | $16.96 | 1 |
| Rigel Pharmaceuticals, Inc. | $13.54 | 1 |
By program year
Records — PY2024 (54)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.